Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 232

The DOI matches its Crossref record.

International Ethical Guidelines for Epidemiological Studies

Rose, Susan · 2009 · American Journal of Epidemiology

Abstract

Many years ago, when I was the Human Subjects Research Program Manager at the US Department of Energy, I was concerned about my lack of jurisdiction over a brand new worker study that had political origins and was going to be conducted without institutional review board (IRB) review or consent. For the workers, possible job loss and nonconsent for use of occupational medical records were problematic. Concerned, I looked for guidance with which to force these “worker studies” to be reviewed as human subjects research. All I found were the 1991 Council for International Organizations of Medical Sciences (CIOMS) Guidelines for Epidemiological Studies. On review, however, I was disappointed by their lack of usefulness and authority for my needs. In desperation, I wrote a handbook myself to set an ethical framework for any worker studies (1). From my current perspective as director of the office that oversees IRBs at the University of Southern California, the 2009 revision of these guidelines, reviewed here, does not provide a US IRB or researcher with the kind of essential materials that I previously sought and are still needed. When CIOMS observed that the research world had changed so much that updating the 1991 guidelines was needed, a debate followed about whether epidemiology/public health guidelines should be a supplement to the CIOMS biomedical guidelines or a stand-alone document. CIOMS chose a stand-alone document. From my perspective, the wrong choice was made. The current text closely follows the content and format of the International Ethical Guidelines for Biomedical Research (2), and the differences are not readily identified. The epidemiology guidelines, however, are obviously useful for non-US researchers who come under the authority of CIOMS or the World Health Organization (WHO), and they will also serve well in any introductory epidemiology methods class for instruction on ethics. For US researchers, they do not have jurisdiction because a firm regulatory structure is in place based on the US regulations for the Protection of Human Subjects 45 Part 46 (3) and the Belmont Report (4). In fact, these 2 documents form the basis of the discussion in both the CIOMS biomedical guidelines and the very similar epidemiology guidelines. The core of the CIOMS document consists of 24 guidelines with commentaries relevant to each and, insofar as possible, specific to epidemiology. The historical background, revision process, introduction, account of earlier instruments, and guidelines are included. An appendix lists items to be included in an epidemiology research protocol involving human subjects, and it also includes the World Medical Association 2008 Declaration of Helsinki. A brief synopsis of the epidemiology guidelines follows: ethics justification and scientific validity; review committees; externally sponsored research; informed consent; compensation; benefits harms and risks; individuals incapable of giving informed consent; research in populations and communities with limited resources; controls in clinical trials; equitable distribution of burdens and benefits; research involving vulnerable persons including children, those with mental and behavioral disorders, and women and pregnant women; safeguarding confidentiality; rights of injured subjects to treatment; infrastructure development; and obligations of external sponsors. Guidelines 22, 23, and 24 do not appear in the biomedical guidelines because only 7 years have elapsed since these biomedical guidelines were written. The 3 guidelines added address disclosure and review of potential conflicts of interest, use of the Internet, and used of stored samples and data. These guidelines apply as well to biomedical research. In the epidemiologic guidelines, the commentaries are thoughtful and very much cutting edge, although not significantly different from those in the biomedical guidelines. There is also considerable blurring between examples that claim to be epidemiologic but strike me as completely biomedical in jurisdiction. I also note recommendations that are ethically pleasing but practically impossible, for example, obligation of external sponsors to provide health care services, IRB review of publication arrangements, and requiring proof of consent from a telephone interview. Other recommendations would not be practicable to effect under the power of the researcher or the IRB. The epidemiology guidelines were developed under the skilled leadership of Michel B. Vallotton, Professor, Swiss Academy of Medical Sciences and President of CIOMS (Chair) and Alexander M. Capron, Professor of Law and Medicine, University of Southern California, formerly Director, Department of Ethics, Trade, Human Rights, and Health Law, WHO (Principal Rapporteur). Under the aegis of CIOMS/WHO, the roster of contributors, expert consultants, and organization is impressive and appropriate. This work should find traction in the international epidemiology community, it

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/aje/kwp334

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 232

Metadata

Authors
Rose, S.
Venue
American Journal of Epidemiology
Published
2009-10-28
Volume
170
Issue
11
Pages
1451-1452
ISSN
  • 0002-9262 (ISSN-L)
  • 1476-6256
OpenAlex
W2108178005
Cited by
232
References
0
FWCI
16.67
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: International Ethical Guidelines for Epidemiological Studies. https://app.cochat.ai/papers/10.1093/aje/kwp334
The paper
Rose, S. (2009). International Ethical Guidelines for Epidemiological Studies. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwp334

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.